Hiroaki Kaku

2PUBLICATIONS
0CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 29, 2024
A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death.

Allison R Balaj, Hiroaki Kaku

|Oct 14, 2022
Small Heat Shock Proteins Collaborate with FAIM to Prevent Accumulation of Misfolded Protein Aggregates.

Hiroaki Kaku, Allison R Balaj, Thomas L Rothstein

Pageof 1

Frequent Collaborators